Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 869 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Oncotype DX Breast Cancer Test May Be Less Accurate for Black... February 26, 2021 Study of More than Half a Million Women Links Regular Mammograms... March 10, 2021 Helping Dogs—and Humans—with Cancer: NCI’s Comparative Oncology Studies July 10, 2019 Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among... May 7, 2025 Load more HOT NEWS Colonoscopy after Positive FIT Test Cuts Risk of Colorectal Cancer Death We’re asking scientists to tackle 9 of the toughest challenges in... Our nurses answer your frequently asked questions about cancer New on NCI’s Websites for June 2022
